10
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1554L |
HPV16 E7 (86-93) acetate
HPV16 E7 (86-93) acetate(160212-93-1 Free base) |
Others | Others |
HPV16 E7 (86-93) acetate 是人源白细胞抗原 A2.1 限制性 HPV16 E7 的衍生肽,在宫颈癌中具有免疫原性。 | |||
TP1554 |
HPV16 E7 (86-93)
|
||
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be used in vaccines for the prevention a | |||
TP1525 |
HPV16 E7 (86-93) (TFA)(160212-93-1,free)
HPV16 E7 (86-93) (TFA) |
||
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. | |||
TP1515 |
HPV16-E711-20 epitope
|
||
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. | |||
T76015 |
HPV16 E7 (86-93) (TFA)
|
||
HPV16 E7 (86-93) TFA,一种HLA-A2.1限制的HPV16 E7衍生肽,在宫颈癌中显示出免疫原性。 | |||
T12711 |
Retro-2 cycl
RN 1-001 |
Virus Protease | Microbiology/Virology |
Retro-2 cycl 是一种抗病毒剂,是一种逆行运输抑制剂,抑制 JCPyV(IC50s:54 μM)和 HPV16 假病毒(IC50s:160 μM)。 | |||
T36432 |
A2ti-1
|
Virus Protease | Microbiology/Virology |
A2ti-1 是一种具有高选择性的附件蛋白 A2/S100A10 杂四聚体(A2t)抑制剂(IC50 : 24 μM), 抑制ARV介导的Src和p38丝裂原活化蛋白激酶(MAPK)的激活。A2ti-1 可用于研究人类乳头瘤病毒 16 型(HPV16)感染。 | |||
T36433 |
A2ti-2
A2ti-2 |
Virus Protease; Antiviral | Immunology/Inflammation; Microbiology/Virology |
A2ti-2 是一种亲和力较低且具有选择性的膜联蛋白 A2/S100A10 异四聚体 (A2t) 抑制剂(IC50 : 230 μM)。A2ti-2 具有抗病毒活性,可选择性破坏 A2 和 S100A10 之间的蛋白质相互作用,可防止人乳头瘤病毒 16 型 (HPV16) 感染。 | |||
T76960 | Verpasep caltespen | ||
Verpasep caltespen (HspE7) 是一种重组融合蛋白,来源于Mycobacterium bovis Calmette-Guérin 热休克蛋白 65 (Hsp65),其 C 末端与HPV16 的 E7 蛋白共价连接。Verpasep caltespen 可用于人乳头瘤病毒 (HPV)引起的癌前病变和癌性病变研究。 | |||
T80375 |
Human α-defensin 5
|
Parasite | Microbiology/Virology |
Human α-defensin 5 是抗病毒肽,能够阻断多种无包膜病毒感染,如AdV、HPV以及多瘤病毒(IC50: HPV16为0.6-1.25 μM)。它通过与病毒衣壳结合来阻止病毒从内体逃逸,并能增强HIV与细胞表面的结合作用。此外,Human α-defensin 5 还具备对抗寄生虫的活性。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-01505 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated
E7,MHC,HPV16 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01504 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi)
MHC,HPV16,E7 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01506 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi)
HPV16,E7,MHC |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01467 |
HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein, Human, MHC (His & Avi)
HPV16,E6,Human papillomavirus type 16<... |
Human | HEK293 Cells |
Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer. | |||
TMPK-01466 |
HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Tetramer Protein, Human, MHC (His & Avi)
Human papillomavirus type 16,E6,HPV16<... |
Human | HEK293 Cells |
Human papillomavirus (HPV) 16 infection is a necessary condition for the pathogenesis and development of cervical cancer. The E6 protein is expressed by the HPV16 E6 gene and promotes malignant phenotype transformation, which is an important mechanism for the occurrence and development of cervical cancer. | |||
TMPH-01584 |
KRT7 Protein, Human, Recombinant (His & SUMO)
|
Human | E. coli |
Blocks interferon-dependent interphase and stimulates DNA synthesis in cells. Involved in the translational regulation of the human papillomavirus type 16 E7 mRNA (HPV16 E7). |